Evidence map›Paper›PMID 39892689›Full record

ArticleBiological psychiatry2025

Interneuron Loss and Microglia Activation by Transcriptome Analyses in the Basal Ganglia of Tourette Disorder.

Yifan Wang, Liana Fasching, Feinan Wu, Milovan Suvakov, Anita Huttner, Sabina Berretta, Rosalinda Roberts, James F Leckman, Thomas V Fernandez, Alexej Abyzov and 1 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Tourette syndrome.Nature reviews. Disease primers · 2026
    Review
  2. Article
  3. Article
  4. [Volatile oil fromNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Yifan WangDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
Liana FaschingChild Study Center, Yale University, New Haven, Connecticut.
Feinan WuChild Study Center, Yale University, New Haven, Connecticut.
Milovan SuvakovDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
Anita HuttnerDepartment of Pathology, Yale University, New Haven, Connecticut.
Sabina BerrettaMcLean Hospital, Harvard Medical School, Belmont, Massachusetts.
Rosalinda RobertsDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama.
James F LeckmanChild Study Center, Yale University, New Haven, Connecticut.
Thomas V FernandezChild Study Center, Yale University, New Haven, Connecticut. Electronic address: thomas.fernandez@yale.edu.
Alexej AbyzovDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: abyzov.alexej@mayo.edu.
Flora M VaccarinoChild Study Center, Yale University, New Haven, Connecticut; Department of Neuroscience, Yale University, New Haven, Connecticut; Yale Kavli Institute for Neuroscience, New Haven, Connecticut. Electronic address: flora.vaccarino@yale.edu.

Funding

Neurodevelopment of Tourette syndromeR01MH118453 · NIMH · YALE UNIVERSITY · PI FLORA M VACCARINO · 2019 to 2026
$4.0M
NIMH NIH HHS R01 MH118453
6 · The paper itself

Abstract

backgroundTourette disorder (TS) is characterized by motor hyperactivity and tics that are believed to originate in the basal ganglia. Postmortem immunocytochemical analyses has revealed decreases in cholinergic (CH), as well as parvalbumin and somatostatin GABA (gamma-aminobutyric acid) interneurons (INs) within the caudate/putamen of individuals with TS.

methodsWe obtained transcriptome and open chromatin datasets by single-nucleus RNA sequencing and single-nucleus ATAC sequencing, respectively, from caudate/putamen postmortem specimens of 6 adults with TS and 6 matched normal control subjects. Differential gene expression and differential chromatin accessibility analyses were performed in identified cell types.

resultsThe data reproduced the known cellular composition of the human striatum, including a majority of medium spiny neurons (MSNs) and small populations of GABA-INs and CH-INs. INs were decreased by ∼50% in TS brains, with no difference in other cell types. Differential gene expression analysis suggested that mitochondrial oxidative metabolism in MSNs and synaptic adhesion and function in INs were both decreased in subjects with TS, while there was activation of immune response in microglia. Gene expression changes correlated with changes in activity of cis-regulatory elements, suggesting a relationship of transcriptomic and regulatory abnormalities in MSNs, oligodendrocytes, and astrocytes of TS brains.

conclusionsThis initial analysis of the TS basal ganglia transcriptome at the single-cell level confirms the loss and synaptic dysfunction of basal ganglia INs, consistent with in vivo basal ganglia hyperactivity. In parallel, oxidative metabolism was decreased in MSNs and correlated with activation of microglia cells, which is attributable at least in part to dysregulated activity of putative enhancers, implicating altered epigenomic regulation in TS.

Indexed as

Basal GangliaInterneuronsMicrogliaTourette SyndromeTranscriptomeAdultFemaleGene Expression ProfilingHumansMaleMiddle AgedHumanInterneuronsMicrogliaMultiomicsStriatumTourette disorder

Identifiers

PMID39892689
PMCPMC12255533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.